Currently browsing: Blog posts
Media Categories
Upcoming Speaking Roles
Research led by @GeiselMed shows that #epigeneticscreening can predict #pancreaticcancer prognosis and also whether #tumors are likely to respond to therapy or not. https://www.clinicalomics.com/topics/oncology/pancreatic-cancer/epigenetic-screening-predicts-pancreatic-cancer-prognosis-and-treatment-sensitivity/ #oncology #cancer #sequencing
To celebrate #pride month, @cenmag highlights the long-standing contributions of #LGBTQ+ chemists. These historic scientists influenced agriculture, #3Dprinting, inorganic chemistry, and more. https://cen.acs.org/people/lgbtq-scientist-chemist-history/99/web/2021/06 #Pride2021 #PrideMonth #PrideMonth2021
The importance of this approval for #cancer #immunotherapy can't be overstated. Esophageal/GEJ cancer is a terrible disease- and for all the successes for immunotherapy over the last decade, it's the adjuvant setting where the greatest number of cures may be achievable. https://twitter.com/endpts/status/1395762012467175430
In a first for immunotherapies, Bristol Myers Squibb’s PD-1 blockbuster Opdivo won another #FDA approval, this time for the adjuvant treatment of completely resected esophageal or gastroesophageal junction cancer with residual pathologic disease.
https://endpts.com/bristol-myers-squibbs-opdivo-leads-the-pack-with-fda-approval-for-resected-esophageal-or-gej-cancer/
Interesting new study: researchers have shown that the supercoiling characteristic of #DNA's structure controls #geneexpression, rather than being a collateral damage to be solved as had been thought to date. Learn more here: https://www.drugtargetreview.com/news/91030/structure-of-dna-actively-involved-in-genome-regulation-study-shows/ #genomics #genomicregulation